Spore Therapy Cuts C. Difficile Reinfection by 68% in 8-Week Study Spore Therapy Cuts C. Difficile Reinfection by 68% in 8-Week Study

An experimental 3-day therapy that adds Firmicutes spores to the gut can reduce the risk of C. difficile reinfection by 68%, according to the results from an 8-week phase 3 study.Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Infectious Diseases News Source Type: news